<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/60F7078B-C2F1-4B3C-9002-4478A5AB5D95"><gtr:id>60F7078B-C2F1-4B3C-9002-4478A5AB5D95</gtr:id><gtr:name>Fixed Phage Limited</gtr:name><gtr:address><gtr:line1>STERLING HOUSE , 20 RENFIELD STREET</gtr:line1><gtr:city>GLASGOW</gtr:city><gtr:postCode>G2 5AP</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/60F7078B-C2F1-4B3C-9002-4478A5AB5D95" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>60F7078B-C2F1-4B3C-9002-4478A5AB5D95</gtr:id><gtr:name>Fixed Phage Limited</gtr:name><gtr:address><gtr:line1>STERLING HOUSE , 20 RENFIELD STREET</gtr:line1><gtr:city>GLASGOW</gtr:city><gtr:postCode>G2 5AP</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>25000.0</gtr:offerGrant><gtr:projectCost>25000.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1DCCC5C7-1B97-4F00-98C1-4F5D9F8D7478"><gtr:id>1DCCC5C7-1B97-4F00-98C1-4F5D9F8D7478</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Mattey</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=130935"><gtr:id>4E3C499B-9A03-4FD2-B4BE-1CA14DB14747</gtr:id><gtr:title>Efficacy of antibacterial active packaging</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Feasibility Studies</gtr:grantCategory><gtr:grantReference>130935</gtr:grantReference><gtr:abstractText>Bacteriophages can be covalently immobilised onto plastics and papers used in packaging, to give a true active antibacterial packaging. The resulting packaging Micro products have a shelf life in excess of 6 months, giving them the potential to be manufactured and distributed as conventional packaging materials, while retaining enough activity to provide consumer protection and enhanced shelf life. The packaged product is not adulterated with the antibacterial agent as this remains firmly and covalently bound to the packaging and is only activated in the presence of the target bacteria. Such a product could reduce the incidence of food poisoning and the amount of waste food.</gtr:abstractText><gtr:fund><gtr:end>2013-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2012-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>25000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">130935</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>